University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...

University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...

Research highlights the potential for modifying the chemical structures of psychedelics to produce analogues with improved efficacy and safety profiles.

A tool based on machine learning from routine clinical data may be useful in predicting the transition to schizophrenia and bipolar disorders.

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.

Cody Balmer's mom told PennLive she called police three nights before the arson to try to get him involuntarily committed to ...

Since its discovery in the 1940s, LSD has fascinated the scientific world for its profound effects on perception, ...

What causes schizophrenia? This severe mental illness, which affects more than 20 million people worldwide and is characterized by recurrent hallucinations and delusions, often begins to emerge in the ...

UC Davis researchers developed JRT, a modified version of LSD that promotes neuroplasticity without hallucinogenic effects.

Johnson & Johnson reported first-quarter revenue and profit above Wall Street estimates on Tuesday, driven by strong cancer drug sales, and provided its first forecast that accounts for trade tariffs ...

A new LSD-derived compound called JRT shows promise for treating schizophrenia and other brain disorders without inducing hallucinations.

The modified LSD, which they named JRT, did just that—and more. It stimulated neurons to sprout new dendritic branches and ...